Parallax Volatility Advisers’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.9M Hold
102,300
0.02% 401
2026
Q1
$14.4M Hold
102,300
0.04% 315
2025
Q4
$17.8M Sell
102,300
-105,500
-51% -$19.3M 0.04% 329
2025
Q3
$29.9M Buy
207,800
+22,500
+12% +$2.76M 0.05% 221
2025
Q2
$18.6M Hold
185,300
0.04% 289
2025
Q1
$14.1M Sell
185,300
-35,100
-16% -$2.68M 0.04% 358
2024
Q4
$15.2M Sell
220,400
-103,400
-32% -$7.45M 0.03% 424
2024
Q3
$23.6M Sell
323,800
-198,900
-38% -$14.7M 0.04% 294
2024
Q2
$35M Buy
522,700
+497,700
+1,991% +$19.3M 0.08% 194
2024
Q1
$678K Sell
25,000
-5,100
-17% -$143K ﹤0.01% 1324
2023
Q4
$933K Buy
+30,100
New +$781K ﹤0.01% 1436
2019
Q1
Sell
-5,000
Closed -$66K 3379
2018
Q4
$66K Sell
5,000
-65,000
-93% -$1.04M ﹤0.01% 2045
2018
Q3
$1.42M Buy
70,000
+50,000
+250% +$1.13M ﹤0.01% 1153
2018
Q2
$473K Buy
+20,000
New +$515K ﹤0.01% 1281

Other funds holding INSM

Parallax Volatility Advisers's INSM Position: Q2 2026 in Review

Parallax Volatility Advisers sold out of Insmed (INSM) in Q2 2026, closing a stake of 150 shares — an estimated $18.2K sold.

Parallax Volatility Advisers first reported a position in INSM in Q2 2014 and held it in 18 quarters. The position peaked at $12.3M in Q2 2024. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Parallax Volatility Advisers reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
  • Parallax Volatility Advisers sold 150 Insmed shares in Q2 2026, an estimated $18.2K.
  • Parallax Volatility Advisers first reported a position in Insmed in Q2 2014 and held it in 18 quarters.
  • Parallax Volatility Advisers's Insmed position peaked at $12.3M in Q2 2024.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Parallax Volatility Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.